China’s Junshi Nabs FDA Approval in Rare Success for US Foray

A Doctor With Brain Cancer Is Helping Transform Its Treatment

Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion

China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US

Pfizer Misses Quarterly Sales Estimates, Lowering Outlook

Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut